FDA NDC Directory · JSON-LD · Markdown

Cathflo Activase

NDC 50242-041 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Generic nameAlteplase
Labeler / ManufacturerGenentech, Inc.
Marketing categoryBiologic License Application · App BLA103172
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · INTRAVENOUS
Active ingredientsALTEPLASE (2.2 mg/2mL)
Marketing started20010904
Package count2

External sources

Source: openFDA. Public-domain (CC0).